Clinical trials
Phase 1/2 Neoplasm Metastasis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
262 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 6 |
| 2002 | 5 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 11 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 8 |
| 2009 | 9 |
| 2010 | 8 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 9 |
| 2014 | 12 |
| 2015 | 3 |
| 2016 | 10 |
| 2017 | 10 |
| 2018 | 10 |
| 2019 | 10 |
| 2020 | 16 |
| 2021 | 29 |
| 2022 | 25 |
| 2023 | 23 |
| 2024 | 6 |
| 2025 | 11 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 85 |
| Terminated | 73 |
| Recruiting | 57 |
| Active, not recruiting | 29 |
| Unknown status | 9 |
| Withdrawn | 6 |
| Suspended | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 16 |
| M.D. Anderson Cancer Center | 13 |
| Memorial Sloan Kettering Cancer Center | 7 |
| Duke University | 4 |
| Incyte Biosciences International Sàrl | 4 |
| NextCure, Inc. | 4 |
| Altor BioScience | 3 |
| Biogen | 3 |
| Bristol-Myers Squibb | 3 |
| Dana-Farber Cancer Institute | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 262 |
| Neoplasms | 53 |
| Melanoma | 47 |
| Carcinoma, Non-Small-Cell Lung | 46 |
| Colorectal Neoplasms | 42 |
| Breast Neoplasms | 34 |
| Lung Neoplasms | 30 |
| Pancreatic Neoplasms | 27 |
| Ovarian Neoplasms | 25 |
| Colonic Neoplasms | 23 |
Trials
Showing 1 to 25 of 262. Each trial links to its page on Pharma Observatory.
162 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.